Actionable news
0
All posts from Actionable news
Actionable news in NVS: NOVARTIS AG,

Novartis broadens cancer immune therapy pipeline with acquisition, pacts

(Adds details, background throughout)

ZURICH, Oct 21 (Reuters) - Novartis has broadened its immuno-oncology pipeline with the acquisition of Admune Therapeutics and through licensing agreements with small drug developers Xoma and Palobiofarma.

Palobiofarma, a Spanish biotech company, said separately it entered into a $15 million licensing agreement with the Swiss group.

Novartis said in a statement on Wednesday these transactions add Admune's IL-15 agonist programme, Palobiofarma's adenosine receptor and Xoma's TGF-beta inhibition programs to its own immuno-oncology portfolio.

Novartis, the world's biggest drugmaker by revenue, is...


More